(IN BRIEF) Health Canada has approved functional claims for Novonesis’ probiotic strain CLEPIUS™, acknowledging its efficacy in alleviating symptoms of irritable bowel syndrome (IBS) and improving quality of life in adults. The authorization encompasses a range of benefits, including relief … Read the full press release →
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged abdominal pain, CLEPIUS™, diarrhea, Digestive Discomfort, Health Canada, irritable bowel syndrome (IBS), Jakob D. Rasmussen, Niklas Larsson, Novonesis, partnership, probiotic strain, stress, sustainability